Mo1527 HIGH SERUM LEVELS OF INTERLEUKIN-10, MACROPHAGE COLONYSTIMULATING FACTOR AND SOLUBLE CD40L INDEPENDENTLY PREDICT 90-DAY MORTALITY IN SEVERE ...

Sa1591 LIVER DECOMPENSATION AND MORTALITY OUTCOMES USING BAVENO VII CUTOFFS FOR TRANSIENT ELASTOGRAPHY AMONG PATIENTS WITH COMPENSATED ADVANCED CHRONIC ...

153 MACHINE LEARNING-BASED PREDICTION OF MORTALITY AMONG MALNOURISHED PATIENTS HOSPITALIZED WITH INFLAMMATORY BOWEL DISEASE

Tu1019 IMPACT OF RACIAL DISPARITIES IN THE QUALITY OF COLONOSCOPY SCREENING ON COLORECTAL CANCER INCIDENCE AND MORTALITY: A SIMULATION MODELING ANALYSIS

99 LEAN VETERANS WITH MASLD HAVE SIGNIFICANTLY GREATER RISK OF CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY COMPARED TO OVERWEIGHT/OBESE VETERANS WITH ...

Tu1575 MAPPING THE BILIARY TRACT: A THREE-DECADE ANALYSIS OF INCIDENCE AND MORTALITY TRENDS IN THE UNITED STATES, A STATE-LEVEL ANALYSIS FROM 1990-2019

684 THE LIVER FRAILTY INDEX (LFI) IMPROVES MORTALITY RISK PREDICTION OVER MELD 3.0 ALONE FOR WOMEN, OLDER ADULTS, AND OBESE PATIENTS WITH CIRRHOSIS

Sa1616 MORTALITY RATES AMONG PATIENTS SUCCESSFULLY TREATED FOR HEPATITIS C: A REAL WORLD MULTINATIONAL COHORT STUDY

850 PATIENTS WITH MAFLD TAKING GLUCAGON LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT HAVE HIGHER INCIDENCE FOR HEPATOBILIARY CANCER BUT HAVE LOWER OVERALL ...

Mo1251 TEMPORAL TRENDS FOR STOMACH CANCER PREMATURE MORTALITY: A GLOBAL STUDY